Past forums
The Foundation's Past Forums showcases our rich history of specialized, high-impact cancer research meetings spanning over 35 years. These forums have brought together leading scientists and clinicians to foster deep dialogue and collaboration through expert-led sessions, with distinguished chairs and top-tier participants driving innovative insights in oncology.
Targeting Mitochondria in Cancer (immuno)therapy
May 15, 2025
-
May 18, 2025
RNA Modifications in mRNA Translation and Cancer
2025 Spring Scholar Retreat
Nanyang Technological University
Alejandro Sweet-Cordero
,
MD
University of California, San Francisco
Mitochondrial Stress in Cancer
April 3, 2025
-
April 6, 2025
Marina Konopleva
,
MD, PhD
Albert Einstein College of Medicine
Harnessing stroma-immune interactions for anti-cancer therapy
March 27, 2025
-
March 30, 2025
MD Anderson Cancer Center
Sex Differences in Etiology, Epidemiology, and Treatment of Cancer
February 27, 2025
-
March 2, 2025
Oregon Health & Science University
Addressing Disparities Among Populations in Cancer Research
December 12, 2024
-
December 15, 2024
Carla Daniela Robles-Espinoza
,
PhD
Intl. Lab for Human Genome Research, U. of Mexico
The Children's Hospital of Philadelphia
Cellular Quiescence and Tumor Dormancy
November 14, 2024
-
November 17, 2024
November 7, 2024
-
November 10, 2024
Children's Hospital Los Angeles
Dana-Farber Cancer Institute
Environment, Host and Tumor Interactions
October 13, 2024
-
October 16, 2024
Monash University Australia
2024 Fall Scholar Retreat
September 26, 2024
-
September 29, 2024
Children's Hospital Los Angeles
National Cancer Institute
Alejandro Sweet-Cordero
,
MD
University of California, San Francisco
Molecular Mechanisms Driving Metastasis
September 19, 2024
-
September 22, 2024
Salvador Aznar Benitah
,
PhD
Institute for Research in Biomedicine, Barcelona
Raul Mostoslavsky
,
MD, PhD
Harvard University
Mechanisms of Cancer Genome Rearrangements
August 18, 2024
-
August 21, 2024
UT Southwestern Medical Center
Isidro Cortes Ciriano
,
PhD
EMBL-EBI
Non-genetic Drug Tolerance Mechanisms
May 12, 2024
-
May 15, 2024
National University of Singapore
Anthony G. Letai
,
MD, PhD
Dana-Farber Cancer Institute
2024 Spring Scholar Retreat
Children's Hospital of Philadelphia
Andrei Thomas-Tikhonenko
,
PhD
University of Pennsylvania
Cancer and Nanotechnology
February 8, 2024
-
February 11, 2024
UT Southwestern Medical School
Uncovering New Mechanisms of LKB1
October 19, 2023
-
October 22, 2023
2023 Fall Scholar Retreat
October 12, 2023
-
October 15, 2023
University of California, San Francisco
Vanderbilt University Medical Center
Alejandro Sweet-Cordero
,
MD
University of California, San Francisco
Systemic Metabolism in Cancer
September 28, 2023
-
October 1, 2023
Matthew Vander Heiden
,
MD, PhD
Koch Institute at MIT
The Biology and Treatment of Hepatocellular Carcinoma
September 28, 2023
-
October 1, 2023
Massachusetts General Hospital
National Institutes of Health
Therapeutic Targeting of mRNA Splicing in Cancer
September 21, 2023
-
September 24, 2023
Olga Anczukow-Camarda
,
PhD
The Jackson Laboratory
Andrei Thomas-Tikhonenko
,
PhD
University of Pennsylvania
Targeting Lipid Biology in Cancer
September 21, 2023
-
September 24, 2023
Sanford Burnham Prebys Medical Discovery Institute
2023 Spring Scholar Retreat
National Cancer Institute
Radiotherapy and Immunotherapy Combination
April 27, 2023
-
April 30, 2023
January 26, 2023
-
January 29, 2023
Mutational Signatures in Pediatric Cancer-from Etiology to Therapeutic Implications
January 26, 2023
-
January 29, 2023
National Cancer Institute
The Hospital for Sick Children
St. Jude Children's Research Hospital
Biomolecular Condensates in Cancer
November 17, 2022
-
November 20, 2022
Johns Hopkins Bloomberg School of Public Health
Washington University School of Medicine in St. Louis
St. Jude Children's Research Hospital
New Insights into the Role of Microbes in Cancer
November 3, 2022
-
November 6, 2022
2022 Fall Scholar Retreat
October 13, 2022
-
October 16, 2022
Alejandro Sweet-Cordero
,
MD
University of California, San Francisco
UT Southwestern Medical School
University of Pennsylvania
Cancer and Genomic Dark Matter
May 12, 2022
-
May 15, 2022
Kathleen H. Burns
,
MD, PhD
Dana-Farber Cancer Institute
Washington University School of Medicine in St. Louis
2022 Spring Scholar Retreat
Dana-Farber Cancer Institute
Case Western Reserve University
Aneuploidy in Cancer Development, Prognosis and Treatment
April 21, 2022
-
April 24, 2022
Instituto de Biologia Molecular e Celular - Universidade do Porto
University of Milan and European Institute of Oncology, Milan, Italy
Dynamic Histone Methylation and Chromatin Organization in Tumor Suppression
March 31, 2022
-
April 3, 2022
Vanderbilt University Medical Center
University of North Carolina
The Genesis and Function of Extrachromosomal Oncogene Amplifications in Cancer
March 24, 2022
-
March 27, 2022
Case Western Reserve University
The Jackson Laboratory of Genomic Medicine
Challenges and Opportunities for Transformative Therapeutic Development for Ovarian Cancer
March 10, 2022
-
March 13, 2022
Neuroendocrine Cell Fate in Development and Cancer
March 10, 2022
-
March 13, 2022
Columbia University Irving Medical Center
Diet and Metabolic Therapeutics in Cancer
February 3, 2022
-
February 6, 2022
University of California, Los Angeles
Cellular Reprogramming and Metastatic Disease
December 2, 2021
-
December 5, 2021
KU Leuven University, Belgium
Raul Mostoslavsky
,
MD, PhD
Harvard University
Emerging Strategies to Overcome Heterogeneous Resistance Mechanisms
October 28, 2021
-
October 31, 2021
Immunotherapies and Mechanisms of Immune Escape
October 28, 2021
-
October 31, 2021
Dana-Farber Cancer Institute
2021 Fall Scholar Retreat
October 14, 2021
-
October 17, 2021
Targeted Therapies in Pediatric Cancers
September 9, 2021
-
September 12, 2021
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
Leveraging Synthetic Lethality to Treat Cancer
February 20, 2020
-
February 23, 2020
SEngine Precision Medicine
Fred Hutchinson Cancer Research Center
November 7, 2019
-
November 10, 2019
Telomerase-Mediated Telomere Targeting in Cancer
October 17, 2019
-
October 20, 2019
UT Southwestern Medical Center
October 10, 2019
-
October 13, 2019
University of North Carolina
Diffuse Intrinsic Pontine Glioma
October 3, 2019
-
October 6, 2019
The Hospital for Sick Kids
Leukemia Stem Cells, Heterogeneity, and Metabolism
September 12, 2019
-
September 15, 2019
University of Pennsylvania
3D Chromosomal Architecture and Nuclear Topology
November 8, 2018
-
November 11, 2018
Dana-Farber Cancer Institute
Children's Hospital of Philadelphia
November 1, 2018
-
November 4, 2018
Oregon Health & Science University
October 11, 2018
-
October 14, 2018
Julie-Aurore Losman
,
MD, PhD
Dana Farber Cancer Institute
September 27, 2018
-
September 30, 2018
Johns Hopkins Oncology Center
Van Andel Research Institute
Metabolic Signaling and the Epigenome
September 13, 2018
-
September 15, 2018
Julie-Aurore Losman
,
MD, PhD
Dana Farber Cancer Institute
University of Pennsylvania
Convergence of Myc and Ras in Cancer
November 9, 2017
-
November 12, 2017
Bringham and Women's Hospital and Harvard Medical School
October 12, 2017
-
October 15, 2017
Massachusetts General Hospital
Precision Cancer Medicine by Functional Biomarkers
March 19, 2017
-
March 20, 2017
Anthony G. Letai
,
MD, PhD
Dana-Farber Cancer Institute
Chromosomal Instability and Aneuploidy
November 10, 2016
-
November 13, 2016
Massachusetts Institute of Technology
Dana-Farber Cancer Institute
October 13, 2016
-
October 16, 2016
Children's Hospital of Philadelphia
Renal Medullary Carcinoma
April 22, 2016
-
April 23, 2016
Vanderbilt University Medical Center
MD Anderson Cancer Center
November 12, 2015
-
November 15, 2015
Children's National Health System The George Washington University
University of Pennsylvania
October 1, 2015
-
October 4, 2015
Vanderbilt University Medical Center
November 6, 2014
-
November 9, 2014
London Health Sciences Centre
September 11, 2014
-
September 14, 2014
Extracellular Vesicles: Promises and Pitfalls
April 12, 2014
-
April 13, 2014
November 7, 2013
-
November 10, 2013
Jeffrey Engelman
,
MD, PhD
Novartis Institutes for BioMedical Research, Inc.
September 12, 2013
-
September 15, 2013
Dana-Farber Cancer Institute
November 1, 2012
-
November 4, 2012
Beth Isreal Deaconess Medical Center
September 13, 2012
-
September 15, 2012
Anthony G. Letai
,
MD, PhD
Dana-Farber Cancer Institute
Bypassing the Blood Brain Barriers to Improve Drug Delivery to Tumor in the Central Nervous System
February 23, 2012
-
February 26, 2012
Robert Wechsler-Reya
,
PhD
Sanford-Burnham Medical Research Institute
Epigenetics & Drug Therapy
November 3, 2011
-
November 7, 2011
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Research Center
September 15, 2011
-
September 18, 2011
Massachusetts General Hospital
Childhood Germ Cell Tumors: Origins, Models & New Treatment Paradigms
March 5, 2011
-
March 7, 2011
Children's Hospital Los Angeles
Dana-Farber Cancer Institute
November 4, 2010
-
November 7, 2010
Dana-Farber Cancer Institute
Wellcome Sanger Institute
September 16, 2010
-
September 19, 2010
University of North Carolina
The Biology And Treatment Of Primary Brain Tumors
November 5, 2009
-
November 8, 2009
UT Southwestern Medical Center
September 17, 2009
-
September 20, 2009
Immunotherapy And Breaking Tolerance
November 6, 2008
-
November 9, 2008
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Research Center
September 11, 2008
-
September 14, 2008
Dana-Farber Cancer Institute
November 1, 2007
-
November 4, 2007
Cold Spring Harbor Laboratory
September 13, 2007
-
September 16, 2007
November 2, 2006
-
November 5, 2006
Massachusetts General Hospital
September 14, 2006
-
September 17, 2006
Innovations in Imaging in Cancer Research
November 3, 2005
-
November 6, 2005
University of California Los Angeles
Ralph Weissleder
,
MD, PhD
Massachusetts General Hospital
September 15, 2005
-
September 18, 2005
Dana-Farber Cancer Institute
Molecular Targets in Pediatric Malignancies
November 4, 2004
-
November 7, 2004
Howard Hughes Medical Institute
University of California Los Angeles
Fertility And Reproductive Issues In Survivors Of Childhood Cancer
September 30, 2004
-
October 3, 2004
Memorial Sloan Kettering Cancer Center
DNA Damage & Cancer Susceptibility Syndromes
November 6, 2003
-
November 9, 2003
Dana-Farber Cancer Institute
The New Biology of Enigmatic Neuroblastoma and Relevant Treatment Strategies
March 22, 2003
-
March 23, 2003
Boston Children's Hospital
Cellular Senescence and Cancer
November 7, 2002
-
November 10, 2002
St Jude Children's Research Hospital
A New Tool in Cancer Medicine: Exploiting the Patient’s Immunological Memory
April 19, 2002
-
April 21, 2002
Philipp Beckhove
,
MD, PhD
German Cancer Research Center
Differentiation as Cancer Therapy
December 1, 2001
-
December 4, 2001
Raymond Paul Warrell, Jr.
,
MD
Genta Incorporated
Mechanisms, Consequences, and Therapeutic Implications of Blood Vessel Leakiness in Cancer
October 4, 2001
-
October 7, 2001
Donald M. McDonald
,
MD, PhD
University of California, San Francisco
Allogeneic Stem Cell Transplantation
December 1, 2000
-
December 4, 2000
Frederick R. Applebaum
,
MD
Fred Hutchinson Cancer Center
Proteases as Cancer Therapeutic Targets
January 23, 2000
-
January 3, 2000
Targeting Gene Therapy - A Reality?
November 4, 1999
-
November 7, 1999
June 3, 1999
-
June 6, 1999
University of Minnesota Cancer Center
St. Jude Childresn's Research Hospital
Dendritic Cell Approaches to Immunotherapy
April 1, 1999
-
April 4, 1999
Massachusetts General Hosp Cancer Center
Tumor Invasion and Metastasis
February 7, 1999
-
February 10, 1999
Tumor Biology Research Institute
Angiogenesis and Accessibility
November 5, 1998
-
November 8, 1998
